TRDA

Entrada Therapeutics (TRDA) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov^[3], including 2 Phase 2^[1], 2 Phase 1^[2].

TRDA has 1 Form 4 insider filing recorded at the SEC in the past 30 days^[4].